JP2020529845A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020529845A5 JP2020529845A5 JP2020505248A JP2020505248A JP2020529845A5 JP 2020529845 A5 JP2020529845 A5 JP 2020529845A5 JP 2020505248 A JP2020505248 A JP 2020505248A JP 2020505248 A JP2020505248 A JP 2020505248A JP 2020529845 A5 JP2020529845 A5 JP 2020529845A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- pharmaceutical composition
- wnt3a
- seq
- wnt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024075397A JP2024120178A (ja) | 2017-08-01 | 2024-05-07 | Ｗｎｔ組成物および無血清培養条件からの処理の方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762539960P | 2017-08-01 | 2017-08-01 | |
| US62/539,960 | 2017-08-01 | ||
| US201862630448P | 2018-02-14 | 2018-02-14 | |
| US62/630,448 | 2018-02-14 | ||
| PCT/US2018/044886 WO2019028186A1 (en) | 2017-08-01 | 2018-08-01 | WNT COMPOSITIONS AND METHODS OF TREATMENT FROM SERUM-FREE CULTURE CONDITIONS |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024075397A Division JP2024120178A (ja) | 2017-08-01 | 2024-05-07 | Ｗｎｔ組成物および無血清培養条件からの処理の方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020529845A JP2020529845A (ja) | 2020-10-15 |
| JP2020529845A5 true JP2020529845A5 (https=) | 2021-09-09 |
Family
ID=65234165
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505248A Pending JP2020529845A (ja) | 2017-08-01 | 2018-08-01 | Ｗｎｔ組成物および無血清培養条件からの処理の方法 |
| JP2024075397A Pending JP2024120178A (ja) | 2017-08-01 | 2024-05-07 | Ｗｎｔ組成物および無血清培養条件からの処理の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024075397A Pending JP2024120178A (ja) | 2017-08-01 | 2024-05-07 | Ｗｎｔ組成物および無血清培養条件からの処理の方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200399588A1 (https=) |
| EP (1) | EP3661475A4 (https=) |
| JP (2) | JP2020529845A (https=) |
| CN (1) | CN111182880B (https=) |
| AU (1) | AU2018309026A1 (https=) |
| CA (1) | CA3071638A1 (https=) |
| GB (2) | GB2581882B (https=) |
| WO (1) | WO2019028186A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019121846A1 (en) * | 2017-12-19 | 2019-06-27 | CSL Behring Lengnau AG | Protein purification and virus inactivation with alkyl glycosides |
| WO2021213623A1 (en) * | 2020-04-20 | 2021-10-28 | Pharmact Holding Ag | A modified bacterial hyaluronidase polypeptide, production process, pharmaceutical compositions and their uses |
| CN116359367B (zh) * | 2022-12-27 | 2023-08-25 | 绍兴市食品药品检验研究院 | 一种同位素内标高效液相色谱串联质谱法检测食品中γ-氨基丁酸的方法 |
| US20260023050A1 (en) * | 2024-07-22 | 2026-01-22 | Waters Technologies Corporation | Methods for analyzing lipid nanoparticles and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0707472T3 (da) * | 1993-07-08 | 2001-04-17 | Liposome Co Inc | Fremgangsmåde til regulering af størrelsen af liposomer |
| US6610316B2 (en) * | 1997-05-30 | 2003-08-26 | Shanbrom Technologies, Llc | Disinfection by particle-bound and insolubilized detergents |
| WO2006036175A2 (en) * | 2004-09-21 | 2006-04-06 | Rhode Island Hospital, A Lifespan-Partner | Wnt proteins and detection and treatment of cancer |
| US20070072238A1 (en) * | 2005-09-26 | 2007-03-29 | Wyeth | Wnt-frizzled chimera |
| US8431532B2 (en) * | 2010-06-28 | 2013-04-30 | Five Prime Therepeutics, Inc. | FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using same |
| AU2012308476B2 (en) * | 2011-09-16 | 2016-04-14 | Fate Therapeutics, Inc. | Wnt compositions and therapeutic uses of such compositions |
| WO2014066328A1 (en) * | 2012-10-23 | 2014-05-01 | Oncomed Pharmaceuticals, Inc. | Methods of treating neuroendocrine tumors using wnt pathway-binding agents |
| WO2015051122A2 (en) * | 2013-10-02 | 2015-04-09 | The Board Of Trustees Of The Leland Stanford Junior University | Wnt compositions and methods for purification |
| CN108601818A (zh) * | 2016-01-28 | 2018-09-28 | 小利兰·斯坦福大学托管委员会 | Wnt组合物及其无血清合成方法 |
-
2018
- 2018-08-01 JP JP2020505248A patent/JP2020529845A/ja active Pending
- 2018-08-01 GB GB2001567.3A patent/GB2581882B/en not_active Expired - Fee Related
- 2018-08-01 CN CN201880064338.XA patent/CN111182880B/zh not_active Expired - Fee Related
- 2018-08-01 GB GB2216232.5A patent/GB2610090B/en not_active Expired - Fee Related
- 2018-08-01 EP EP18840842.1A patent/EP3661475A4/en not_active Withdrawn
- 2018-08-01 CA CA3071638A patent/CA3071638A1/en active Pending
- 2018-08-01 WO PCT/US2018/044886 patent/WO2019028186A1/en not_active Ceased
- 2018-08-01 AU AU2018309026A patent/AU2018309026A1/en not_active Abandoned
-
2020
- 2020-08-18 US US16/996,676 patent/US20200399588A1/en not_active Abandoned
-
2024
- 2024-05-07 JP JP2024075397A patent/JP2024120178A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020529845A5 (https=) | ||
| JP6348946B2 (ja) | 延長組換えポリペプチドおよび延長組換えポリペプチドを含む組成物 | |
| JP5755398B2 (ja) | 伸長されたｇｌｐ−１化合物 | |
| JP4585037B2 (ja) | アシル化ｇｌｐ−１化合物 | |
| JP6519929B2 (ja) | Ｇｌｐ−１類似体融合タンパク質とその作製方法及び用途 | |
| CN101842386A (zh) | 截短的glp-1衍生物和它们的治疗用途 | |
| JP2015057058A (ja) | 組織傷害の修復におけるストロマ細胞由来因子１のプロテアーゼ耐性変異体 | |
| FI3510049T3 (fi) | Happo alfa-glukosidaasin muunnoksia ja niiden käyttöjä | |
| KR20160138133A (ko) | 안정화된 피브로넥틴 기반 스캐폴드 분자 | |
| US20240400628A1 (en) | Polypeptides, nucleic acid molecules, compositions, and related methods | |
| JP2024120178A (ja) | Ｗｎｔ組成物および無血清培養条件からの処理の方法 | |
| FI4034555T3 (fi) | Dap10/dap12-fuusiopolypeptidit | |
| PE20020857A1 (es) | Proteinas de fusion cuya parte del n-terminal es un derivado de hirudina para la produccion de proteinas recombinantes a traves de la secresion por levaduras | |
| JP2004505601A5 (https=) | ||
| EP0528686B8 (en) | Process for producing peptides | |
| JP2009519296A (ja) | ポリペプチド延長タグ | |
| US6337194B1 (en) | Method for the preparation of insulin by cleavage of a fusion protein and fusion proteins containing insulin A and B chains | |
| Käkönen et al. | Purification and characterization of recombinant osteocalcin fusion protein expressed inEscherichia coli | |
| KR102201154B1 (ko) | 폴리글루타메이트-TAT-Cre 융합 단백질의 제조방법 | |
| JP5877988B2 (ja) | 蛍光タンパク質を用いた分子認識センサー、分子放出複合体及びその合成 | |
| US11034946B2 (en) | Glycosylation independent proteins | |
| CA2247998C (en) | Fragments of cr1 and their use | |
| De Simone et al. | Single-step purification of class 5 outer membrane protein from Neisseria meningitidis using preparative electrophoresis | |
| Langoscha et al. | Lehrstuhl Chemie der Biopolymere, Technische Universität München, Weihenstephaner Berg 3, 85354 Freising (Germany), Fax:+ 49-8161-714404, e-mail: langosch@ lrz. tum. de b University of Osnabrück, Department of Biology, Biochemistry, Barbarastrasse 13, 49076 Osnabrück (Germany) | |
| LI et al. | LI Su-Xia et al.: Expression of C-peptide Multiple Gene Copies in Escherichia coli |